Browse articles from EyeWorld.org related to MIGS. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

EyeWorld Weekly, November 11, 2022

➤ Phase 1/2a results for suprachoroidal wet AMD treatment ➤ Enrollment complete for two Phase 2 trials investigating dry eye therapies disease ➤ Phase 2b study for drug-eluting contact lens begins ➤ Healthcare company acquires biopharmaceutical company developing ophthalmic treatments ➤ Development and commercialization licensing agreement ➤ ASOA podcast features dry eye info for the practice ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, November 11, 2022

A perspective on FLACS and glaucoma

While some studies have found that femtosecond laser-assisted cataract surgery does not offer a significant benefit over traditional phaco, many surgeons still find it helpful in the setting of certain comorbidities. For Robert Noecker, MD, one of these is glaucoma.

Comments Off on A perspective on FLACS and glaucoma

EyeWorld Weekly, September 9, 2022

➤ Autologous stem cell therapy to treat dry AMD ➤ Topline results from Phase 3 trial for GA therapy ➤ Update on Phase 3 myopia progression clinical trial ➤ FDA accepts NDA application for investigational dry eye therapy ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, September 9, 2022

EyeWorld Weekly, August 19, 2022

➤ Long-term safety, efficacy data reported from standalone MIGS procedure ➤ Positive clinical data in ongoing trial for investigational thyroid eye disease treatment ➤ Bioengineered cornea restores vision in 20 people ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, August 19, 2022

EyeWorld Weekly, August 12, 2022

➤ FDA approves first standalone MIGS device ➤ Phase 3 clinical study results for inflammation, pain management nanosuspension ➤ Phase 2a clinical trial begins for investigational MGD treatment ➤ Registry created to collect data on canaloplasty ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, August 12, 2022

EyeWorld Weekly, May 20, 2022

➤ Phase 4 results evaluating intravitreal implant ➤ Interim results for X-linked retinitis pigmentosa treatment ➤ New non-contact glaucoma laser treatment receives CE mark ➤ Companies collaborate for regenerative dry eye therapy ➤ Complimentary MIGS video series ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, May 20, 2022

Insights on adopting new technologies

New innovations are entering the glaucoma space on a regular basis, but how do physicians discern whether (and when) to adopt them and what is that process like? Two physicians shared their considerations and experiences with bringing new techniques and technologies into practice.

Comments Off on Insights on adopting new technologies

EyeWorld Onsite, April 23, 2022

➤ Roberto Zaldivar, MD, delivers the Steinert Lecture ➤ Richard Lindstrom, MD, gives Obstbaum Lecture ➤ Video cases offer a ‘Reay of Hope’ at Glaucoma Day ➤ Cornea Day covers topics in keratoconus, corneal ectasia, lamellar surgery

Comments Off on EyeWorld Onsite, April 23, 2022

EyeWorld Weekly, April 1, 2022

➤ FDA approves new ICL ➤ Home tonometer receives 510(k) clearance ➤ First patient treated in what will be the largest standalone MIGS clinical trial ➤ Topline results from second Phase 3 trial of mydriasis-reversing drug ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, April 1, 2022
Read more about the article No change? No chance
Nathan Radcliffe, MD Glaucoma Editor

No change? No chance

EyeWorld Glaucoma Editor Nathan Radcliffe, MD, previews the articles in the Glaucoma section of the issue, specifically highlighting some of the advances and changes coming to the field.

Comments Off on No change? No chance